Serum proteomics (Olink) data of childhood-onset SLE patients and healthy controls

Published: 30 January 2026| Version 1 | DOI: 10.17632/fwsw46ktyp.1
Contributor:
George Robinson

Description

Targeted serum proteomics was conducted using the Olink Target 96 immune response panel on a cohort of childhood-onset SLE patients (n=55) and matched healthy controls (n=14). Data is displayed as NPX values.

Files

Institutions

Categories

Proteomics

Funders

Licence